Apart from amplification, the constitutive activation of RET is caused by point mutations and gene rearrangements that drive malignancy in multiple tissues (i.e., papillary and medullary thyroid carcinomas and non-small cell lung carcinomas) [128,129,130,131]. The gene discussed is RET; the disease is medullary thyroid gland carcinoma.